Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins. In this half-day virtual summit, a series of ...

Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed ...

Original story from Technion-Israel Institute of Technology (Haifa, Israel). An implantable tissue flap containing muscle and ...

GlyphAgo achieved therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes ...

Skin, our largest organ, acts as a protective barrier against pathogens that try to invade our bodies while constantly ...

Through the agreement, Sub-Q Bionics has licensed clinical know-how from Mayo Clinic related to reconstructive and lymphatic surgery. As part of this collaboration, Vahe Fahradyan ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned ...

Scientists are using proteomics to decode the complex biology of endometriosis, revealing protein patterns that could enable earlier, non-invasive diagnosis and more personalized care.

Researchers have discovered that cancer spread isn’t random—it follows a kind of biological “program.” By studying colon ...